Lilly cancer push boosted by survival benefit to key drug
(Credit: Eli Lilly & Co. )
Nearly two years after the first U.S. approval of Eli Lilly's breast cancer drug Verzenio, the company said Tuesday interim data f...
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.